Publication of a Supplementary Prospectus

Summary by AI BETAClose X

Investec Bank plc has published a Base Prospectus Supplement dated 22 September 2026, which has been approved by the United Kingdom Financial Conduct Authority. This supplement relates to the company's existing £6,000,000,000 Euro Medium Term Note Programme.

Disclaimer*

Investec Bank PLC
22 September 2026
 

Investec Bank plc

Incorporated in England and Wales

Registration number 489604

LEI: 84S0VF8TSMH0T6D4K848

 

Date: 22 September 2026

 

Publication of Base Prospectus Supplement

 

The following document has been approved by the United Kingdom Financial Conduct Authority and is available for viewing:

 

Base Prospectus Supplement dated 22 September 2026 relating to Investec Bank plc's £6,000,000,000 Euro Medium Term Note Programme.

 

To view the full document, please paste the following URL into the address bar of your browser.

 

http://www.rns-pdf.londonstockexchange.com/rns/8362V_1-2026-9-22.pdf

  

FURTHER INFORMATION

For further information please contact:

Derek Lloyd

E-mail: Derek.Lloyd@investec.co.uk

Telephone: +44 20 7597 2945

 

DISCLAIMER - INTENDED ADDRESSEES

 

Please note that the information contained in the Base Prospectus Supplement may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Base Prospectus as defined in the Base Prospectus Supplement) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Base Prospectus is not addressed. Prior to relying on the information contained in the Base Prospectus you must ascertain from the Base Prospectus whether or not you are part of the intended addressees of the information contained therein.

 

Your right to access this service is conditional upon complying with the above requirement.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings